Advertisement
Loading...

Harrow Health, Inc.

HROW•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$31.21
$0.35(1.13%)
U.S. Market opens in 28h 25m

Harrow Health, Inc. (HROW) Stock Overview

Explore Harrow Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-77.13
EPS (TTM)$-0.38
ROE-0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$45.53
3 Months$45.44
1 Year Target$50.93

HROW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Harrow Health, Inc. (HROW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 31.10, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $50.93.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -77.13 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.13%
5-Day Change
-20.08%
1-Month Change
-19.54%
3-Month Change
-34.56%
6-Month Change
-23.49%
Year-to-Date (YTD) Change
-36.31%
1-Year Change
21.82%
3-Year Change
49.40%
5-Year Change
234.15%
All-Time (Max) Change
21.87%

Contact Information

https://www.harrowinc.com
615 733 4730
102 Woodmont Boulevard, Nashville, TN, 37205

Company Facts

382 Employees
IPO DateSep 28, 2007
CountryUS
Actively Trading

Frequently Asked Questions